Evidence map›Paper›PMID 38710683›Full record

ArticleNature communications2024

BERNN: Enhancing classification of Liquid Chromatography Mass Spectrometry data with batch effect removal neural networks.

Simon J Pelletier, Mickaël Leclercq, Florence Roux-Dalvai, Matthijs B de Geus, Shannon Leslie, Weiwei Wang, TuKiet T Lam, Angus C Nairn, Steven E Arnold, Becky C Carlyle and 2 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Metabolic footprint of sepsis and septic shock: A narrative review.World journal of critical care medicine · 2026
    Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Simon J PelletierComputational Biology Laboratory, CHU de Québec - Université Laval Research Center, Québec City, QC, Canada.
Mickaël LeclercqComputational Biology Laboratory, CHU de Québec - Université Laval Research Center, Québec City, QC, Canada.
Florence Roux-DalvaiComputational Biology Laboratory, CHU de Québec - Université Laval Research Center, Québec City, QC, Canada.ORCID http://orcid.org/0000-0002-9961-8964
Matthijs B de GeusMassachusetts General Hospital Department of Neurology, Charlestown, MA, USA.ORCID http://orcid.org/0000-0003-1615-9393
Shannon LeslieYale Department of Psychiatry, New Haven, CT, USA.
Weiwei WangKeck MS & Proteomics Resource, Yale School of Medicine, New Haven, CT, USA.
TuKiet T LamKeck MS & Proteomics Resource, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-4850-3462
Angus C NairnYale Department of Psychiatry, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-7075-0195
Steven E ArnoldMassachusetts General Hospital Department of Neurology, Charlestown, MA, USA.
Becky C CarlyleMassachusetts General Hospital Department of Neurology, Charlestown, MA, USA.ORCID http://orcid.org/0000-0003-1491-3217
Frédéric PreciosoUniversité Côte d'Azur, CNRS, INRIA, I3S, Sophia Antipolis, Nice, France.
Arnaud DroitComputational Biology Laboratory, CHU de Québec - Université Laval Research Center, Québec City, QC, Canada. arnaud.droit@crchudequebec.ulaval.ca.ORCID http://orcid.org/0000-0001-7922-790X

Funding

Research Education ComponentP30AG062421 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Christine S Ritchie · 2019 to 2026
$36.5M
Yale Alzheimer Disease Research CenterP30AG066508 · NIA · YALE UNIVERSITY · PI STEPHEN M STRITTMATTER · 2020 to 2026
$30.2M
The Massachusetts and Yale ADRC Collaborative Proteomic Biofluid Biomarker Discovery ProgramR01AG062306 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI ARNOLD, STEVEN E, CARLYLE, BECKY CATHERINE · 2018 to 2022
$3.5M
6500 QTrap Mass Spectrometer for Yale UniversityS10OD018034 · OD · YALE UNIVERSITY · PI MANE, SHRIKANT M · 2014 to 2014
$514k
NIA NIH HHS P30 AG062421NIA NIH HHS P30 AG066508NIA NIH HHS R01 AG062306NIH HHS S10 OD018034
6 · The paper itself

Abstract

Liquid Chromatography Mass Spectrometry (LC-MS) is a powerful method for profiling complex biological samples. However, batch effects typically arise from differences in sample processing protocols, experimental conditions, and data acquisition techniques, significantly impacting the interpretability of results. Correcting batch effects is crucial for the reproducibility of omics research, but current methods are not optimal for the removal of batch effects without compressing the genuine biological variation under study. We propose a suite of Batch Effect Removal Neural Networks (BERNN) to remove batch effects in large LC-MS experiments, with the goal of maximizing sample classification performance between conditions. More importantly, these models must efficiently generalize in batches not seen during training. A comparison of batch effect correction methods across five diverse datasets demonstrated that BERNN models consistently showed the strongest sample classification performance. However, the model producing the greatest classification improvements did not always perform best in terms of batch effect removal. Finally, we show that the overcorrection of batch effects resulted in the loss of some essential biological variability. These findings highlight the importance of balancing batch effect removal while preserving valuable biological diversity in large-scale LC-MS experiments.

Indexed as

Liquid Chromatography-Mass SpectrometryNeural Networks, ComputerReproducibility of Results

Identifiers

PMID38710683
PMCPMC11074280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.